MORGAN STANLEY - SECOND SIGHT MED PRODS INC ownership

SECOND SIGHT MED PRODS INC's ticker is EYES and the CUSIP is 81362J209. A total of 21 filers reported holding SECOND SIGHT MED PRODS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of SECOND SIGHT MED PRODS INC
ValueSharesWeighting
Q2 2022$472,000
-41.4%
232,673
-58.7%
0.00%
Q1 2022$805,000
-52.5%
563,207
-45.8%
0.00%
Q4 2021$1,693,000
+257.2%
1,038,237
+597.7%
0.00%
Q3 2021$474,000
+3850.0%
148,805
+6115.7%
0.00%
Q2 2021$12,000
-40.0%
2,394
-2.3%
0.00%
Q1 2021$20,000
+5.3%
2,450
-76.5%
0.00%
Q4 2020$19,000
+111.1%
10,4070.0%0.00%
Q3 2020$9,000
-10.0%
10,407
-0.1%
0.00%
Q2 2020$10,000
-9.1%
10,418
-1.6%
0.00%
Q1 2020$11,00010,5880.00%
Other shareholders
SECOND SIGHT MED PRODS INC shareholders Q1 2020
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 291,973$931,0000.13%
Virtu Financial LLC 43,729$139,0000.01%
Jump Financial, LLC 30,551$97,0000.01%
Hudson Bay Capital Management LP 150,404$480,0000.01%
Paloma Partners Management Co 67,406$215,0000.01%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 68,100$217,0000.00%
Tower Research Capital LLC (TRC) 31,568$101,0000.00%
Stratos Wealth Partners, LTD. 15,543$50,0000.00%
OPPENHEIMER & CO INC 23,013$73,0000.00%
Cutler Group LLC / CA 3,931$12,0000.00%
View complete list of SECOND SIGHT MED PRODS INC shareholders